In Nature this week: draft genomes of cultivated Upland cotton, and more.
In a New York Times op-ed, Eric Lander argues that forensic science needs to be of high quality.
Newt Gingrich calls for a doubling of the National Institutes of Health budget.
Color Genomics, a low-cost breast cancer genetic testing company, enters the fray, while others band together to work out the meaning of variants of unknown significance.
In Genome Biology this week: investigation of host expression and microbial communities in pouchitis, liver fluke genome sequencing, and more.
Researchers plan to share Ebola and MERS viral sequence data more quickly.
Penn State researchers home in on a gene linked to the melting point of chocolate.
Stanford University's Karl Deisseroth and Xiaoliang Sunney Xie from Harvard University are this year's recipients of the Albany Medical Center Prize.
In PNAS this week: microbial communities of household dust, sequencing study of desiccation tolerance in the Resurrection Plant, and more.
Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.
FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.
Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.
In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.
The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.
Nature has retracted a 2002 epigenetics paper for image manipulation.
African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.
In Science this week: measles virus nucleocapsid structure, and more.
Hopkins researchers report that matched tumor-normal pairs are necessary to identify and interpret mutations found in patients' tumors.
The University of California is questioning the Broad Institute CRISPR patents, Tech Review reports.
Republicans on the House science committee put forth an America COMPETES Act reauthorization bill.
In Nature this week: genomic imprinting maps, spatial origin of cells, and more.
IBM and its partners look to combine health information to develop a health platform for the Watson supercomputer.
BioMed Central's Rafal Marszalek discusses the surging popularity of genome editing.
In Nucleic Acids Research this week: approach to assess multiple protein sequence alignments, method to characterize alternative splicing events from RNA-seq data, and more.
Scientists in British Columbia are setting up a genomic surveillance system for avian influenza.